Updating results

36 results for LUTS

Sort: Date | Relevance

Urogenital conditions

Everything NICE has said on urogenital conditions in an interactive flowchart

NICE Pathway Published June 2015 Last updated November 2019

Medicines and technologies programme: adoption team

NICE Medicines and technologies programme: adoption team

Published September 2019 Last updated September 2019

Prostatitis – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for acute prostatitis in an interactive flowchart.

NICE Pathway Published October 2018 Last updated September 2019

Shared decision making (KTT23)

This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

Key therapeutic topic Published March 2019 Last updated September 2019

Urinary incontinence and pelvic organ prolapse in women

Everything NICE has said about managing urinary incontinence and pelvic organ prolapse in women in an interactive flowchart

NICE Pathway Published September 2013 Last updated July 2019

Shared learning awards previous winners and finalists

procedure, an ambulatory pathway for patients suffering from Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia New IV Fluids:...

Published June 2019 Last updated June 2019

ADXBLADDER for detecting bladder cancer (MIB180)

Advice on ADXBLADDER for detecting bladder cancer to aid local decision making

Medtech innovation briefing Published April 2019

Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG641)

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia

Interventional procedures guidance Published January 2019

Lower urinary tract symptoms in men

Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart

NICE Pathway Published October 2012 Last updated January 2019

Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG629)

Evidence-based recommendations on transurethral water jet ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published September 2018

Rezum for treating benign prostatic hyperplasia (MIB158)

Advice on the use of Rezum (NxThera Inc) for treating benign prostatic hyperplasia (BPH) to aid local decision-making

Medtech innovation briefing Published August 2018

Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG625)

Evidence-based recommendations on transurethral water vapour ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published August 2018

Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG611)

Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults

Interventional procedures guidance Published April 2018

Suspected cancer: recognition and referral (NG12)

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.

NICE guideline Published June 2015 Last updated July 2017

Infracoccygeal sacropexy using mesh to repair uterine prolapse (IPG582)

Evidence-based recommendations on infracoccygeal sacropexy using mesh to repair uterine (womb) prolapse in women

Interventional procedures guidance Published June 2017

Improving the quality of care for men with lower urinary tract symptoms: shared decision making

with lower urinary tract symptoms (LUTS). Clinical peer review was focused on evidence of implementation of NICE guidance...

QP Case Study Published July 2016

Research recommendations

encourages further research into transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic...

Published April 2016 Last updated April 2016

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (BHP)

Medical technologies guidance Published September 2015

Lower urinary tract symptoms in men: management (CG97)

This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.

Clinical guideline Published May 2010 Last updated June 2015

Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia (IPG475)

Evidence-based recommendations on prostatic urethral lift implants to treat lower tract symptoms secondary to benign prostate hyperplasia (enlarged prostate)

Interventional procedures guidance Published January 2014

Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil (ESNM18)

Summary of the evidence on tadalafil for lower urinary tract symptoms secondary to benign prostate hyperplasia..

Evidence summary Published May 2013 Last updated October 2013

Quality standard highlights need for greater awareness of men presenting with LUTS

NICE?s quality standard lower urinary tract symptoms (LUTS) highlights the need for greater awareness of the initial assessment and management of the condition.

News Published September 2013 Last updated September 2013

Nocturia and nocturnal polyuria in men with lower urinary tract symptoms: oral desmopressin (ESUOM10)

This evidence summary has been withdrawn because a product containing oral desmopressin with a marketing authorisation for treating nocturia and nocturnal polyuria in men with lower urinary tract symptom is now available in the UK.

Evidence summary Published April 2013

Urinary incontinence in neurological disease: assessment and management (CG148)

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.

Clinical guideline Published August 2012

Holmium laser prostatectomy (IPG17)

Evidence-based recommendations on holmium laser prostatectomy (removal of the prostate) for treating Benign prostatic obstruction (BPO)

Interventional procedures guidance Published November 2003

Transurethral electrovaporisation of the prostate (IPG14)

Evidence-based recommendations on transurethral electrovaporisation of the prostate (TURP) to treat benign prostatic obstruction (BPO)

Interventional procedures guidance Published October 2003

Lower urinary tract symptoms

All NICE products on lower urinary tract symptoms. Includes any guidance, advice, NICE Pathways and quality standards.

Topic page

Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia

In development [GID-MT529] Expected publication date: 06 April 2020

Medical technologies guidance In development